ClinicalTrialsFinder
RecruitingNot ApplicableNCT07815496

The Effects of Oxytocin on Fairness Perception and Related Prosocial Behaviors

The Modulatory Effects of Oxytocin on Fairness Perception and Related Prosocial Behaviors

Sponsor

University of Electronic Science and Technology of China

Enrollment

80 participants

Start Date

Sep 5, 2026

Study Type

INTERVENTIONAL

Conditions

healthy adult participants

Summary

This study aims to investigate the modulation of intranasally administered oxytocin (24 IU) on human fairness perception and related prosocial behaviors.

Eligibility

Min Age: 18 YearsMax Age: 35 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Oxytocin nasal spray and a drug called Placebo for people with healthy adult participants. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 35 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGOxytocin nasal spray

intranasal administration of oxytocin (24IU)

DRUGPlacebo

intranasal administration of placebo (24IU)

Locations(1)

University of Electronic Science and Technology of China (UESTC)

Chengdu, Sichuan, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07815496

Related Trials

A First-in-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of HMB-003 in Healthy Volunteers

NCT07798505

Phase 1 Study Involving SAB01 and Healthy Participants

NCT07815561

Phase 1 Study of ADX-626 in Healthy Participants

NCT070815031 location

RIG 101 Trial in Healthy Adults and Adults With Asthma

NCT074888972 locations

Alpelisib Challenge Test (ACT)

NCT07778524